Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Benedict

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
A growth factor mixture that significantly enhances angiogenesis in vivoW Roethy, E Fiehn, K Suehiro, et al.
Cancer|October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Cancer|March 16, 2018
Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanomaSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
The Annals of Pharmacotherapy|August 13, 2022
Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney InjuryVictoria L Williams, Pamela L Smithburger, Allison N Imhoff, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 10, 2003
Hereditary hyperferritinemia-cataract syndrome: prevalence, lens morphology, spectrum of mutations, and clinical presentationsJamie E Craig, J Benedict Clark, Janet L McLeod, et al.
Melanoma Research|January 6, 2016
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategySarah Sloot, Jonathan S Zager, Ragini R Kudchadkar, et al.
Bioscience|October 7, 2021
Mapping and Monitoring Zero-Deforestation CommitmentsKemen G Austin, Robert Heilmayr, Jason J Benedict, et al.
The Annals of Pharmacotherapy|April 4, 2017
Results of a Regional Effort to Improve Warfarin ManagementAdam J Rose, Angela Park, Christopher Gillespie, et al.
Acta Neuropathologica Communications|April 26, 2022
Correction to: Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeatLindsey N Campion, Alan Mejia Maza, Rachita Yadav, et al.
Acta Neuropathologica Communications|April 9, 2022
Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeatLindsey N Campion, Alan Mejia Maza, Rachita Yadav, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
A growth factor mixture that significantly enhances angiogenesis in vivoW Roethy, E Fiehn, K Suehiro, et al.
Cancer|October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Cancer|March 16, 2018
Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanomaSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
The Annals of Pharmacotherapy|August 13, 2022
Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney InjuryVictoria L Williams, Pamela L Smithburger, Allison N Imhoff, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 10, 2003
Hereditary hyperferritinemia-cataract syndrome: prevalence, lens morphology, spectrum of mutations, and clinical presentationsJamie E Craig, J Benedict Clark, Janet L McLeod, et al.
Melanoma Research|January 6, 2016
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategySarah Sloot, Jonathan S Zager, Ragini R Kudchadkar, et al.
Bioscience|October 7, 2021
Mapping and Monitoring Zero-Deforestation CommitmentsKemen G Austin, Robert Heilmayr, Jason J Benedict, et al.
The Annals of Pharmacotherapy|April 4, 2017
Results of a Regional Effort to Improve Warfarin ManagementAdam J Rose, Angela Park, Christopher Gillespie, et al.
Acta Neuropathologica Communications|April 26, 2022
Correction to: Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeatLindsey N Campion, Alan Mejia Maza, Rachita Yadav, et al.
Acta Neuropathologica Communications|April 9, 2022
Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeatLindsey N Campion, Alan Mejia Maza, Rachita Yadav, et al.
Pageof 9